의료용 이미징 시약 시장 규모, 점유율, 성장 분석 : 종류별, 기술별, 용도별, 지역별 - 산업 예측(2024-2031년)

Medical Imaging Reagents Market size was valued at USD 19.55 Billion in 2022 and is poised to grow from USD 21.35 Billion in 2023 to USD 43.17 Billion by 2031, at a CAGR of 9.20% during the forecast period (2024-2031).

The Medical Imaging Reagents Market is an essential component of the healthcare sector, providing critical tools for diagnostics and research. These reagents enhance tissue and organ visibility in imaging techniques like MRI, CT, ultrasound, and nuclear medicine. Key market drivers include rising chronic disease rates, an ageing population, and the need for early, accurate diagnoses. The shift towards molecular imaging, offering functional and metabolic insights along with anatomical details, has increased the demand for advanced reagents that target specific molecules for personalized treatment. Ongoing R&D efforts focus on developing safer, more efficient reagents, while hybrid imaging systems like PET/CT and SPECT/CT fuel the need for versatile reagents compatible with multiple platforms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segmental Analysis

The global medical imaging reagents market is segmented on the basis of class, technology, application and region. By class, the market is segmented into Contrast Reagents, Optical Reagents, and Nuclear Reagents. By technology, the market is segmented into Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots. By application, the market is segmented into Diagnostics, Drug Discovery & Development, Educational Research. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Medical Imaging Reagents Market

The rising incidence of chronic diseases like cancer, cardiovascular disorders, and neurological conditions has significantly boosted the need for advanced medical imaging procedures. This surge in demand underscores the critical role of medical imaging reagents, which enhance the precision and efficacy of diagnostic imaging techniques. As these reagents improve the clarity and detail of imaging results, they become indispensable in accurately diagnosing and monitoring these complex diseases, thereby driving their widespread use in the medical field. This trend highlights the vital importance of innovation and accessibility in medical imaging technologies to meet the growing healthcare challenges.

Restraints in the Medical Imaging Reagents Market

Medical imaging reagents, particularly those utilized in advanced imaging modalities such as PET and MRI, often come with high costs. The expenses associated with these reagents, along with the sophisticated equipment and related healthcare services, pose a substantial financial challenge for both healthcare facilities and patients. This economic barrier can hinder the market's expansion, especially in regions with lower income levels, where the financial strain is more pronounced. Consequently, the high costs can restrict access to these advanced imaging techniques, potentially impacting the quality of healthcare and diagnostic capabilities in economically disadvantaged areas.

Market Trends of the Medical Imaging Reagents Market

The demand for molecular imaging reagents, particularly PET and SPECT radiopharmaceuticals, has been on the rise due to their critical role in visualizing and quantifying biological processes at the molecular and cellular levels. This capability is essential for early disease detection, precise treatment planning, and ongoing monitoring. The trend is fueled by advancements in radiopharmaceutical development, which have led to the creation of more targeted and specific imaging agents, enhancing their effectiveness and precision in medical diagnostics and research. These innovations are revolutionizing the field, making molecular imaging an indispensable tool in modern healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Medical Imaging Reagents Market by Class

• Market Overview
• Contrast Reagents
• Optical Reagents
• Nuclear Reagents

Medical Imaging Reagents Market by Technology

• Market Overview
• Nanoparticles
• Fluorescent Dyes & Probes
• Radiopharmaceuticals
• Fluorescent Proteins
• Quantum Dots

Medical Imaging Reagents Market by Application

• Market Overview
• Dignostic
• Drug discovery & Technology
• Educational Research

Medical Imaging Reagents Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Medical Imaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EliTechGroup (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curium Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoScan Imaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eisai Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.B. Chemicals & Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Life Sciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyclopharm Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Life Molecular Imaging (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AdvaCare Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Medical House PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumiphore, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments